The effect of Sujok seed therapy and oral Fenugreek seeds on controlling blood sugar in diabetic patients

Evaluation of the effect of Sujok seed therapy with Fenugreek seeds on controlling blood sugar in diabetic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210902052361N1

Enrollment

180

Registered

2021-10-15

Start date

2021-09-21

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Type 1 diabetes mellitus

Interventions

Intervention 1: Intervention group: In addition to the routine treatment (medications that reduce blood sugar such as Insulin, Metformin, Glibenclamide), 20 Fenugreek seeds are placed and wrapped on t

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 20 to 60 years who have been diagnosed with diabetes for at least one year Patients with type 1 and 2 diabetes Glycosylated hemoglobin above 6.5 Having no complications from diabetes,

Exclusion criteria

Exclusion criteria: Pregnancy Sensitivity to Fenugreek

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose levels and glucose levels two hours after breakfast. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Fat profile. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Level of Hemoglobin A1C. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Serum insulin level. Timepoint: At the beginning of the study and three months later. Method of measurement: Blood test.	—

Measure

Time frame

Fasting blood glucose levels and glucose levels two hours after breakfast. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Fat profile. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Level of Hemoglobin A1C. Timepoint: At the beginning of the study and two weeks, one month and three months later. Method of measurement: Blood test.;Serum insulin level. Timepoint: At the beginning of the study and three months later. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Abbasi

Mashhad University of Medical Sciences

abbasishz@mums.ac.ir+98 51 3871 3801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026